DCA and Sanofi win a GOOD DESIGN® Award

9 March 2017

DCA and Sanofi win a Chicago Athenaeum GOOD DESIGN® award for the new SoliquaTM SoloStar® disposable pen injector. This pen injector contains a new diabetes therapy which combines Lantus®, a long-acting insulin, with lixisenatide, a non-insulin diabetes medicine, in a single once-daily injection.

Now in its 66th year, GOOD DESIGN® is the oldest and most prestigious Awards Program organised worldwide. The Chicago Athenaeum continues the organisation of the programme to create a revived awareness about contemporary design and to honour both products and industry leaders in design and manufacturing that have chartered new directions and pushed the envelope for competitive products in the world marketplace.

GOOD DESIGN® is an international symbol of a company’s firm commitment to innovation and superior design embodiment. Materials and products are accessed into the Museum’s Permanent Design Collection and frequently exhibited in the United States and abroad.

Link to Medical and Scientific
Link to Pharmaceuitical Drug Delivery

DCA and Sanofi win a GOOD DESIGN® Award

You might also like:

Lyxumia® pen wins the Japanese Good Design Award